Metropolis Healthcare Q2 FY27 earnings call: revenue up 16%
FROM THE WIRE · FINANCE.YAHOO.COM
This article first appeared on GuruFocus. Revenue (Q2 FY27): INR4.97 crore, up 16% YoY, driven by 10% patient volume growth and 11% test volume growth. Revenue (H1 FY27): Grew 16.2% YoY, ahead of stated guidance (up from 1213% historical organic growth). EBITDA (Q2 FY27): INR135…
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: expected bullishQuarterly results show growth and margin expansion, a neutral-to-positive read for a mid-cap.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01Q2 FY27 revenue was INR 4.97 crore, up 16% year on year.
- 02EBITDA rose 24% with a 27.2% margin.
- 03Q2 PAT rose 43% year on year.
NEWS IMPACT AND MARKET REACTIONChange since the story · reference
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets